D-0387-2026 Class II Ongoing

Recalled by HTO Nevada Inc. Dba Kirkman — Lake Oswego, OR

FDA drug recall D-0387-2026 was initiated by HTO Nevada Inc. Dba Kirkman on Feb 18, 2026 and is designated Class II. Reason for recall: Stability Data Does Not Support Expiry Date. The recall status is ongoing. Affected quantity: 243 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 11, 2026
Initiation Date
Feb 18, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
243 bottles

Product description

MAXIMUM, ZONE 2, 4% Lidocaine Cream, (Lidocaine 4% and Epinephrine 0.01%), 1 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-015.

Reason for recall

Stability Data Does Not Support Expiry Date.

Distribution pattern

Nationwide within the U.S

Code information

Lot #: 795CP-0005, Exp. Date 06/30/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0387-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0387-2026. Report a data issue: hello@regdatalab.com.